A panel of specialists in China has estimated a 76% increase in cases of hepatocellular carcinoma, from 0.87 million in 2022 to 1.52 million in 2050. The survival rate for this type of cancer is between 5% and 30%. Annual deaths could also increase by 81%, from 0.76 million to 1.37 million. Most cases are preventable, with 60% caused by risk factors such as fatty liver disease and hepatitis B and C virus infections.
Sources
Latest News
10:14
ANAF accounts risk being garnished for judges’ outstanding salaries
09:59
The Pentagon asked the U.S. Central Command to be prepared for potential attacks on Iran / Donald Trump has not yet decided when to launch the attacks (Axios)
09:56
The Edupart Federation calls on Parliament to reject the bill that decriminalizes drug possession for personal use
09:56
Kim Jong Un’s sister calls on South Korea to show “the utmost respect” to resume dialogue between the two countries
09:52
Prosecutors investigate a serious case: a 12-year-old girl was found in the home of an 18-year-old young man / The young man arrested for rape
See more news